CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
nab-paclitaxel (G-nP) or gemcitabine, nab-paclitaxel (G-nP) and atezolizumab in previously untreated subjects with metastatic pancreatic ductal adenocarcinoma...
Phase 1
Birmingham, Alabama, United States
and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma...
Phase 3
Birmingham, Alabama, United States and 185 other locations
Barrett's Esophagus (BE), with or without dysplasia, and esophageal adenocarcinoma (EAC) as compared to Esophagogastroduodenoscopy (EGD) plu...
Birmingham, Alabama, United States and 37 other locations
* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advan...
Phase 1, Phase 2
Birmingham, Alabama, United States and 13 other locations
This is a randomized, phase 1b study to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of sovilnesib at different dose levels t...
Phase 1
Birmingham, Alabama, United States and 12 other locations
This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of...
Phase 1
Birmingham, Alabama, United States and 31 other locations
IIMGN151-1001 is a Phase 1, first in human, open-label dose-escalation, optimization, and expansion study designed to characterize the safety, tolera...
Phase 1
Birmingham, Alabama, United States and 52 other locations
The main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally ad...
Phase 1
Birmingham, Alabama, United States and 57 other locations
This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to...
Phase 1, Phase 2
Birmingham, Alabama, United States and 71 other locations
and bevacizumab in participants who have newly diagnosed metastatic adenocarcinoma of the colon/rectum. The study will also evaluate if the ...
Phase 1, Phase 2
Birmingham, Alabama, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal